Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective
BJ Maron, NAM Estes, EJ Rowin, MS Maron… - Journal of the American …, 2023 - jacc.org
Implantable cardioverter-defibrillators (ICDs) represent transformational technology,
arguably the most significant advance in cardiovascular medicine in 50 years. The vision …
arguably the most significant advance in cardiovascular medicine in 50 years. The vision …
Implantable cardioverter-defibrillators for hypertrophic cardiomyopathy: The Times They Are a-Changin'
The implantable cardioverter-defibrillator (ICD) is a life-saving therapy in patients with
hypertrophic cardiomyopathy (HCM) at high risk of sudden cardiac death. The heterogeneity …
hypertrophic cardiomyopathy (HCM) at high risk of sudden cardiac death. The heterogeneity …
Long-term follow-up of patients with tetralogy of Fallot and implantable cardioverter defibrillator: the DAI-T4F nationwide registry
V Waldmann, A Bouzeman, G Duthoit, L Koutbi… - Circulation, 2020 - Am Heart Assoc
Background: Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart
disease, and sudden cardiac death represents an important mode of death in these patients …
disease, and sudden cardiac death represents an important mode of death in these patients …
Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight …
S Honarbakhsh, A Protonotarios, C Monkhouse… - Europace, 2023 - academic.oup.com
Aims Arrhythmogenic right ventricular cardiomyopathy (ARVC) patients develop ventricular
arrhythmias (VAs) responsive to anti-tachycardia pacing (ATP). However, VA episodes have …
arrhythmias (VAs) responsive to anti-tachycardia pacing (ATP). However, VA episodes have …
[HTML][HTML] Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable …
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) has
demonstrated safety and efficacy for the treatment of malignant ventricular arrhythmias …
demonstrated safety and efficacy for the treatment of malignant ventricular arrhythmias …
Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for …
A Flett, A Cebula, Z Nicholas, R Adam, S Ewings… - American Heart …, 2023 - Elsevier
Background For patients with nonischemic cardiomyopathy (NICM), current guidelines
recommend implantable cardioverter defibrillators (ICD) when left ventricular ejection …
recommend implantable cardioverter defibrillators (ICD) when left ventricular ejection …
[HTML][HTML] Stereotactic management of arrhythmia-radiosurgery in treatment of ventricular tachycardia (SMART-VT). Results of a prospective safety trial
M Miszczyk, M Sajdok, J Bednarek, T Latusek… - Radiotherapy and …, 2023 - Elsevier
Background and purpose Despite its increasing popularity, there are limited prospective
data on stereotactic arrhythmia radioablation (STAR). In this trial, we assessed the safety …
data on stereotactic arrhythmia radioablation (STAR). In this trial, we assessed the safety …
Ventricular arrhythmia detection for contemporary Biotronik and Abbott implantable cardioverter defibrillators with markedly prolonged detection in Biotronik devices
A Oesterle, SS Dhruva, CN Pellegrini, B Liem… - Journal of Interventional …, 2023 - Springer
Abstract Background Implantable cardioverter defibrillators (ICDs) are typically programed
with both ventricular tachycardia (VT) and ventricular fibrillation (VF) treatment zones …
with both ventricular tachycardia (VT) and ventricular fibrillation (VF) treatment zones …
Case series on stereotactic body radiation therapy in non‐ischemic cardiomyopathy patients with recurrent ventricular tachycardia
D Yugo, LW Lo, YH Wu, FP Chung… - Pacing and Clinical …, 2021 - Wiley Online Library
Introduction The efficacy of stereotactic body radiation therapy (SBRT) as an alternative
treatment for recurrent ventricular tachycardia (VT) is still unclear. This study aimed to report …
treatment for recurrent ventricular tachycardia (VT) is still unclear. This study aimed to report …
Ventricular tachycardia incidence and erythrocyte membranes β‐adrenoreactivity in patients with implanted cardioverter‐defibrillator
TA Atabekov, RE Batalov, TY Rebrova… - Pacing and Clinical …, 2022 - Wiley Online Library
Background In patients with high risk of ventricular tachycardia (VT) the proven beneficial
therapy is the implantable cardioverter defibrillator (ICD). It has been shown that the …
therapy is the implantable cardioverter defibrillator (ICD). It has been shown that the …